|
FDA Approves Pfizer's Antiretroviral Maraviroc
2007-08-14 07:52:00 FDA on Monday approved Pfizer antiretroviral drug maraviroc, which belongs to a new class of antiretrovirals that could provide an alternative to HIV-positive people who have developed resistance to multiple drugs, the Los Angeles Times reports. FDA gave expedited approval of maraviroc for use in combination with other antiretrovirals (CQ HealthBeat, 8/6). Maraviroc works by blocking a protein, called CCR5, on human immune system cells that HIV uses as a portal to enter and infect the cell. Pfizer has proposed using the drug to treat people with advanced HIV or AIDS who have not responded to other medications. Pfizer last month also announced that maraviroc can reduce HIV viral loads among people who have never taken antiretrovirals. The company plans to offer the drug with a test developed by Monogram Biosciencesthat determines if people are likely to respond to the treatment (Kaiser Daily HIV/AIDS Report, 7/26). Pfizer will sell maraviroc under the brand name Selzentry (Wall Stre...
Maraviroc, Pfizers New HIV/AIDS Drug
2007-06-13 18:59:00 A new HIV/AIDS medicine is coming out in July after tests being carried out in the United States, by the FDA (Food and Drug Administration),? the head of the firm in South Africa, Richard Paulson said at a briefing to journalists. Full Story...
Maraviroc, Pfizers New HIV/AIDS Drug
2007-06-13 18:59:00 A new HIV/AIDS medicine is coming out in July after tests being carried out in the United States, by the FDA (Food and Drug Administration),” the head of the firm in South Africa, Richard Paulson said at a briefing to journalists. Full Story... |
|
 |
|
 |
